GKBGKB Ophthalmics Limited
Healthcare · Medical Instruments & Supplies · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
GKB Ophthalmics Limited engages in the manufacture and sale of unfinished ophthalmic lenses in India and internationally. It offers semifinished organic lenses, such as single vision, bifocal, and progressive. The company was incorporated in 1981 and is based in Mapusa, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on GKB — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Risk gate: safety score is only 25/100 — volatility, drawdown or liquidity is too poor for a buy call, whatever the chart says
- • Recently listed — limited trading history, scores are provisional
- • Revenue growth: 2.3% YoY
- • ROE: 2.3%
- • Insufficient price history
Bull case
- • Profit growth: 117.3% YoY
- • Debt/Equity: 0.21
- • Promoter holding: 78.0%
- • Volume trend: 2.2x baseline
Bear case
- • Recently listed — limited trading history, scores are provisional
- • Revenue growth: 2.3% YoY
- • ROE: 2.3%
- • Insufficient price history
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Momentum is fading versus the broader market
- • Recently listed — limited trading history, scores are provisional
- • Revenue growth: 2.3% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹3.35). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.